My watch list
my.chemeurope.com  
Login  

Investing in the future: Bohle Technology Center to be opened in March 2015

24-Nov-2014

Despite a reserved investment climate in the pharmaceutical industry, L.B. Bohle Maschinen + Verfahren GmbH has used the 2014 financial year to prepare itself for the future – with a multi-million euro investment. The new Technology Center at its headquarters in Ennigerloh will open in March 2015. It offers customers and researchers an optimal platform for development. Owner Lorenz Bohle has also strengthened the management team. Sales Manager Tim Remmert has been promoted to the Management Board. The Board will also see greater involvement from Dr Hubertus Rehbaum (Research & Development) and Thorsten Wesselmann (Engineering).

“We might not have been able to escape the effects of the difficult market environment,” states Lorenz Bohle matter-of-factly, “but we have retained our leadership position and invested further in innovation.” At Plant 3, further progress has been made in gradually establishing lean production, meaning that production processes have been successfully optimised within a very short period of time.     A sales offensive in Asia and South America, but especially in the recovered US market should see an acceleration in incoming orders across the entire product range.

Platform for knowledge transfer

“At Interpack 2014, we presented an alternative to the Wurster process with the Bohle Uni Cone BUC® process, which coats even the smallest particles more evenly and precisely,” states Lorenz Bohle, setting store by technological advantages as part of the market campaign. The process also allows customers to apply active substances to their products with the highest precision. “Even in very complex processes, the losses are below one percent,” says Bohle.

Starting in March 2015, the Bohle Technology Center will offer customers, researchers and cooperation partners a first-class platform for the development of continuous production processes. In the new, architecturally sophisticated, high-tech building, customers will be presented with solutions for direct compression, wet granulation and dry compaction. “Significant for customers is the permanent and cross-process measuring, monitoring and controlling of production, for which we are now laying the groundwork,” states Lorenz Bohle, setting the objectives. In the designing of the innovative continuous production line in particular, Bohle sees great potential for growth.

Personnel changes

The company owner has also laid the foundations for the future with regard to personnel. “Beginning 1 January 2015, our long-term Sales Manager Tim Remmert will be more  involved in strategic activities,” explains Lorenz Bohle. In addition, Manager Scientific Operations Dr Hubertus Rehbaum has joined the executive ranks as an assistant to the Management Board. Thorsten Wesselmann has taken on the role of Head of Engineering. Armin Bohle resigned from his operational activities with the company at his own request in October 2014, but will continue to support the development of the company as a shareholder.

Growth course firmly in sight

The financial situation of L.B. Bohle Maschinen + Verfahren GmbH remains solid in 2014. “Our equity ratio remains at 50 percent,” reports Lorenz Bohle. Investments will be financed through current operations. “With the drive in America and with the team and potential cooperation partners, we consider ourselves to be solidly positioned for 2015, a year in which we will face considerable challenges owing to the Interphex and ACHEMA trade fairs and the opening of the Technology Center.” As a goal he has set his sights firmly on a return to the growth rates of previous years.

Facts, background information, dossiers
  • Bohle
More about Bohle
  • News

    L.B. Bohle receives ATEX-certification

    The European Union published the ATEX-guideline in 1994 first and in 2014 an amended version was implemented. The guideline 2014/34/EU covers equipment and safety systems that are used in hazardous areas. Among others, the sieving machines BTS 100 and BTS 200 built by L.B. Bohle belong to t ... more

    L.B. Bohle rejuvenates management team

    L.B. Bohle Maschinen + Verfahren GmbH has taken advantage of the 2014 business year to prepare itself for the future with investments of several millions. The newly built Technology Center at the Ennigerloh headquarters was inaugurated in March 2015. "Together with customers, partners and s ... more

    With the Technology Center, L. B. Bohle merges all steps of continuous production for the first time

    For many years now,continuous processes in pharmaceutical production have been the focus of the special machine builders of L.B. Bohle Maschinen + Verfahren GmbH. With the inauguration of the Technology Center, the engineers, scientists, pharmacists and IT developers for the first time clos ... more

  • Videos

    BRC – Compactor & Granulator for Pharmaceutical Production

    Continuous processes with dry granulationDry granulation often is the process of choice for high-volume or moisture-sensitive products. The BRC Granulator by Bohle is suited for continuous production and offers the possibility of integrating Process Analytical Technology (PAT).The benefits ... more

    Corporate Video L.B. Bohle Maschinen + Verfahren GmbH

    more

  • Companies

    L.B. Bohle Maschinen + Verfahren GmbH

    L.B. Bohle Maschinen + Verfahren GmbH is a global acting manufacturer for the pharmaceutical industry. The range of products includes process and handling equipment for the pharmaceutical solids production. The company was founded in 1981 by Mr. Lorenz Bohle. The founder is owner and manag ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE